Ventricular Fibrillation in Acute Coronary Syndrome: Timing and Prognosis

Ventricular fibrillation (VF) is one of the most time-critical complications of acute coronary syndrome (ACS). Ischaemic myocardium creates electrical instability, and a patient with an occluded coronary artery can deteriorate from ventricular tachycardia to pulseless VF within seconds. Survival depends on a coordinated chain of recognition, high-quality cardiopulmonary resuscitation (CPR), rapid defibrillation, coronary reperfusion and post-arrest care.

For clinicians in Australia, this chain crosses several settings: a home in suburban Melbourne, an ambulance travelling across regional New South Wales, a catheterisation laboratory in Brisbane or a rural hospital awaiting retrieval. Understanding how each minute affects rhythm conversion, neurological recovery and long-term prognosis helps teams make sound decisions under pressure.

Why Acute Coronary Ischaemia Triggers VF

During coronary occlusion, reduced oxygen delivery alters membrane potentials, conduction velocity and refractory periods. The border zone between viable and ischaemic myocardium can develop conduction block and re-entry, allowing premature ventricular complexes to initiate ventricular tachycardia or VF. Electrolyte abnormalities, sympathetic activation, acidosis and reperfusion can further increase electrical instability.

VF produces chaotic ventricular activity without effective cardiac output. Within seconds, the patient becomes unresponsive and loses a palpable pulse. Cerebral and myocardial injury begins immediately, while the probability of successful resuscitation falls with every prolonged interval without effective circulation. A rhythm that may be reversible early can become resistant to shocks as hypoxia and acidosis progress.

ACS-related VF can occur before hospital arrival, during emergency department assessment, in the catheterisation laboratory or shortly after reperfusion. Its timing matters prognostically. VF within the first 48 hours of an infarction is often considered a direct complication of acute ischaemia, whereas later ventricular arrhythmia may indicate persistent scar, incomplete revascularisation or an underlying cardiomyopathy.

Defibrillation Is a Race Against Time

For a witnessed, shockable cardiac arrest, immediate defibrillation is the definitive treatment. High-quality CPR maintains a limited level of coronary and cerebral perfusion while a defibrillator is prepared, but CPR cannot reliably terminate VF. A shock delivered within the first few minutes has the greatest chance of restoring an organised rhythm, particularly when the collapse is witnessed and the initial rhythm is VF or pulseless ventricular tachycardia.

Australian emergency systems use 000 for ambulance activation, and dispatcher-assisted CPR can help bystanders act before paramedics arrive. Automated external defibrillators (AEDs) in airports, shopping centres, sporting grounds and workplaces can shorten the interval to the first shock. Public access defibrillation is especially valuable when a collapse occurs in a busy location such as Sydney’s transport network or a community sports facility.

Delays may arise when VF is mistaken for a seizure, when a monitor is not attached promptly or when rescuers pause compressions for too long. The practical priorities are rapid rhythm recognition, pad placement on a bare chest, immediate shock when indicated and prompt resumption of compressions. Biphasic defibrillators are standard in contemporary practice, with energy selected according to the device and local protocol.

The Prehospital Chain In Australia

Paramedics must manage two linked emergencies: cardiac arrest and the coronary occlusion that caused it. Initial treatment includes scene safety, confirmation of unresponsiveness and absent normal breathing, chest compressions, ventilation when appropriate, rhythm analysis and repeated defibrillation for persistent VF. Vascular or intraosseous access, adrenaline and antiarrhythmic therapy may be used according to Australian Resuscitation Council and ambulance-service protocols.

The logistics vary considerably across the country. A patient in inner-city Perth may reach a hospital with percutaneous coronary intervention (PCI) capability quickly, while a person in the Northern Territory or far western Queensland may require prolonged transport and aeromedical retrieval. Ambulance Victoria, NSW Ambulance and other state services use clinical pathways designed to identify STEMI, transmit electrocardiograms where available and bypass hospitals that cannot provide timely reperfusion.

Prehospital teams should communicate the arrest timeline clearly: time of collapse, bystander CPR, first rhythm, number and timing of shocks, return of spontaneous circulation (ROSC), medications and suspected coronary symptoms. This information supports decisions about direct transfer to a PCI-capable centre and helps the receiving team interpret prognosis without relying on an isolated initial examination.

Reperfusion After Return Of Spontaneous Circulation

ROSC does not end the emergency. Persistent coronary occlusion can provoke recurrent VF, cardiogenic shock and further myocardial injury. In patients with ST-segment elevation, ongoing ischaemic symptoms, haemodynamic instability or a high suspicion of coronary occlusion, urgent coronary angiography and PCI are central to management. The timing is determined by the whole clinical picture rather than by a single ECG feature.

The Australian and New Zealand environment includes regional hospitals that stabilise patients before transfer to a tertiary cardiac centre. Early discussion with a PCI service is important when the patient remains unstable, has recurrent ventricular arrhythmia or requires mechanical circulatory support. Transfer decisions should account for transport time, weather, bed availability and the expertise available locally.

Coronary angiography is not automatically beneficial for every comatose survivor of cardiac arrest without evidence of acute occlusion. In patients who are haemodynamically stable and have no convincing STEMI or ongoing ischaemia, a delayed or selective strategy may be appropriate. Clinical judgement, serial ECGs, echocardiography, troponin trends and the arrest context should guide the pathway.

Refractory VF And Escalation

VF that persists after several appropriate shocks is termed refractory or shock-resistant VF. Treatment requires a systematic search for reversible causes, including coronary occlusion, hypoxia, severe acidosis, hypo- or hyperkalaemia, hypothermia, tension pneumothorax, cardiac tamponade and toxicological causes. Pad position, contact, compression quality and defibrillator function should be checked before simply repeating ineffective shocks.

Amiodarone or lidocaine may be considered for refractory VF under local advanced life support protocols. These drugs support defibrillation in selected patients, but they do not replace early shocks, effective CPR or reperfusion. Excessive pauses for drug administration, intubation or transport can reduce the chance of meaningful recovery.

Some centres use double sequential external defibrillation or vector-change strategies for persistent VF, while extracorporeal CPR and mechanical circulatory support may be available in highly selected systems. These approaches require trained teams, rapid referral and clear governance. They should be evaluated in the context of Australian transport distances and the resources of the treating hospital rather than adopted as isolated rescue techniques.

Prognostic Meaning Of Early VF

VF during the acute phase of myocardial infarction does not carry the same prognostic meaning as late ventricular arrhythmia. When VF occurs early, is terminated quickly and follows successful revascularisation, long-term risk may be driven mainly by left ventricular function, infarct size and residual coronary disease. Early VF remains serious, but it is not automatically evidence of a permanent arrhythmic substrate.

Prognosis is strongly influenced by collapse-to-CPR and collapse-to-shock intervals, initial rhythm, duration of arrest, number of defibrillation attempts, ROSC quality and the presence of cardiogenic shock. Neurological outcome depends on cerebral perfusion during resuscitation and the severity of post-cardiac-arrest brain injury. Lactate, echocardiography, renal function and haemodynamic trends help describe illness severity, but no single early marker should determine withdrawal of treatment.

Neurological prognostication should be delayed until confounders such as sedation, neuromuscular blockade, hypothermia and metabolic derangement have been addressed. A multimodal assessment may include serial neurological examination, electroencephalography, neuroimaging and selected biomarkers. Families need clear explanations that recovery can evolve over days, especially when temperature management and sedation obscure the examination.

Preventing Recurrence After Hospital Care

Following ACS-associated VF, clinicians assess ventricular function, completeness of revascularisation, scar burden and the likelihood of recurrent malignant arrhythmia. Guideline-directed medical therapy generally includes antiplatelet treatment, statin therapy, beta-blockade when appropriate and management of heart failure or hypertension. Correcting potassium and magnesium abnormalities is particularly important during the vulnerable inpatient period.

An implantable cardioverter-defibrillator (ICD) is not automatically indicated when VF occurs within the acute infarction window and is clearly attributable to reversible ischaemia. Decisions change when ventricular arrhythmia occurs later, recurs after adequate revascularisation or reflects persistent severe left ventricular dysfunction. Timing also matters because ventricular function can improve during recovery, and early device implantation may not provide the best balance of benefit and risk.

Patients discharged after a coronary event need a plan for cardiac rehabilitation, medication adherence and warning symptoms. Australia’s cardiac rehabilitation services differ between metropolitan hospitals, private providers and rural communities, so referral should be arranged before discharge where possible. Education should cover when to call 000, how to respond to recurrent chest pain and why stopping antiplatelet or heart failure medication without advice can be dangerous.

Building Better Evidence And Practice

Research should report the complete timeline of care rather than defibrillation time alone. Useful variables include witnessed status, bystander CPR, AED use, ambulance response, first monitored rhythm, shock sequence, time to ROSC, ECG findings, coronary anatomy, PCI timing, intensive care treatment and neurological outcome. These data allow investigators to distinguish the impact of rapid defibrillation from the effects of patient selection and hospital capability.

For Australian clinicians and researchers, collaboration across metropolitan and regional networks can reveal where delays occur. Registry work may examine whether telehealth ECG transmission, public AED density, direct transport to PCI centres or structured post-arrest protocols improve survival with good neurological function. Comparisons should account for population distribution, Indigenous health inequities, transport distances and access to specialist electrophysiology services.

Authors preparing research, reviews or educational material for a specialist readership can consult the journal’s author requirements before submission. Sharing rigorous data on shock timing, reperfusion and outcomes strengthens practice across the Asia-Pacific region, where emergency response systems and access to advanced cardiac care vary widely.

Rapid recognition, uninterrupted CPR, immediate defibrillation and timely coronary reperfusion remain the decisive elements in ACS-related VF. Hospitals should rehearse these transitions, audit every arrest, maintain reliable defibrillator access and ensure that rural and metropolitan pathways connect efficiently. Clinicians seeking publication, collaboration or further journal information can use the editorial contact page to engage with the wider arrhythmia community.